Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 12 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2000Microcystins (cyanobacterial toxins) in drinking water enhance the growth of aberrant crypt foci in the mouse colonHumpage, A.; Hardy, S.; Bradford, E.; Froscio, S.; Falconer, I.
2002A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumorsAndersson, P.; McGuire, J.; Rubio, C.; Gradin, K.; Whitelaw, M.; Pettersson, S.; Hanberg, A.; Poellinger, L.
2012PI3Kγ drives priming and survival of autoreactive CD4⁺ T cells during experimental autoimmune encephalomyelitisComerford, I.; Litchfield, W.; Kara, E.; McColl, S.
2012A Combination of Local Inflammation and Central Memory T Cells Potentiates Immunotherapy in the SkinFiorenza, S.; Kenna, T.; Comerford, I.; McColl, S.; Steptoe, R.; Leggatt, G.; Frazer, I.
2010The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responsesComerford, I.; Nibbs, R.; Litchfield, W.; Bunting, M.; Harata-Lee, Y.; Haylock-Jacobs, S.; Forrow, S.; Korner, H.; McColl, S.
2010Cytoxic T cells are the predominant players providing cross-protective immunity induced by y-irradiated influenza A virusesFuruya, Y.; Chan, J.; Regner, M.; Lobigs, M.; Koskinen, A.; Kok, T.; Manavis, J.; Li, P.; Mullbacher, A.; Alsharifi, M.
2009Chromosome Y variants from different inbred mouse strains are linked to differences in the morphologic and molecular responses of cardiac cells to postpubertal testosteroneLlamas, B.; Verdugo, R.; Churchill, G.; Deschepper, C.
2006Persistent Expression of Notch2 Delays Gonadotrope DifferentiationRaetzman, L.; Wheeler, B.; Ross, S.; Thomas, P.; Camper, S.
2006Use of a zinc fluorophore to measure labile pools of zinc in body fluids and cell-conditioned mediaZalewski, P.; TruongTran, A.; Lincoln, S.; Ward, A.; Shankar, A.; Coyle, P.; Jayaram, L.; Copley, A.; Grosser, D.; Murgia, C.; Lang, C.; Ruffin, R.
2020SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic controlMontgomery, M.K.; Bayliss, J.; Devereux, C.; Bezawork-Geleta, A.; Roberts, D.; Huang, C.; Schittenhelm, R.B.; Ryan, A.; Townley, S.L.; Selth, L.A.; Biden, T.J.; Steinberg, G.R.; Samocha-Bonet, D.; Meex, R.C.R.; Watt, M.J.